Search research articles
Contact Us
Filters
Showing results (871-880 of 918) with videos related to
Page
of 92
Sort By:
Blood Cancer Journal
|
August 1, 2018
Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma
Shaji K Kumar, Francis K Buadi, Betsy LaPlant, et al.
Mayo Clinic Proceedings
|
December 4, 2009
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines
Shaji K Kumar, Joseph R Mikhael, Francis K Buadi, et al.
Blood
|
January 29, 2015
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
Antonio Palumbo, Sara Bringhen, Maria-Victoria Mateos, et al.
Leukemia
|
October 14, 2024
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)
Hongwei Tang, Huihuang Yan, Suganti Shivaram, et al.
Blood Cancer Journal
|
May 13, 2020
"Direct to Drug" screening as a precision medicine tool in multiple myeloma
Cecilia Bonolo de Campos, Nathalie Meurice, Joachim L Petit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Thomas Martin, Saad Z Usmani, Jesus G Berdeja, et al.
Mayo Clinic Proceedings
|
August 12, 2006
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma
Martha Q Lacy, Angela Dispenzieri, Morie A Gertz, et al.
Proceedings. Biological Sciences
|
April 21, 2021
A deepening understanding of animal culture suggests lessons for conservation
Philippa Brakes, Emma L Carroll, Sasha R X Dall, et al.
Cancer Cell
|
August 19, 2007
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma
Jonathan J Keats, Rafael Fonseca, Marta Chesi, et al.
Plos One
|
October 17, 2012
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing
Winnie S Liang, David W Craig, John Carpten, et al.
Page
of 92
Search research articles
Search
Showing results (871-880 of 918) with videos related to
Sort By:
Page
of 92
Blood Cancer Journal
|
August 1, 2018
Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma
Shaji K Kumar, Francis K Buadi, Betsy LaPlant, et al.
Mayo Clinic Proceedings
|
December 4, 2009
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines
Shaji K Kumar, Joseph R Mikhael, Francis K Buadi, et al.
Blood
|
January 29, 2015
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
Antonio Palumbo, Sara Bringhen, Maria-Victoria Mateos, et al.
Leukemia
|
October 14, 2024
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)
Hongwei Tang, Huihuang Yan, Suganti Shivaram, et al.
Blood Cancer Journal
|
May 13, 2020
"Direct to Drug" screening as a precision medicine tool in multiple myeloma
Cecilia Bonolo de Campos, Nathalie Meurice, Joachim L Petit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Thomas Martin, Saad Z Usmani, Jesus G Berdeja, et al.
Mayo Clinic Proceedings
|
August 12, 2006
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma
Martha Q Lacy, Angela Dispenzieri, Morie A Gertz, et al.
Proceedings. Biological Sciences
|
April 21, 2021
A deepening understanding of animal culture suggests lessons for conservation
Philippa Brakes, Emma L Carroll, Sasha R X Dall, et al.
Cancer Cell
|
August 19, 2007
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma
Jonathan J Keats, Rafael Fonseca, Marta Chesi, et al.
Plos One
|
October 17, 2012
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing
Winnie S Liang, David W Craig, John Carpten, et al.
Page
of 92